Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology

Feb 15, 2023

Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology

admin2023-02-16T20:02:32-05:00February 15th, 2023|Media|